The Prostate Advances in Comparative Evidence (PACE) study is an international, randomised controlled trial comparing SBRT to image-guided radiotherapy and surgery for treating prostate cancer. PACE is sponsored by the Royal Marsden NHS Foundation Trust.
Learn more about PACE by reading the trial summary - here.
Dr. Nicholas van As presented the acute toxicity results from PACE-B at the ASCO GU annual conference in San Francisco. An overview of the information presented can be found here.